Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patients.

Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patients. Dig Liver Dis. 2012 Jan; 44(1):74-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.